Investindustrial announced that it is acquiring DCC Healthcare. The acquisition values DCC Healthcare at a total enterprise value of £1 billion ($1.4 billion USD) on a cash-free, debt-free basis. Arthur Cox advised Investindustrial in the deal.
DCC Healthcare is the healthcare unit of DCC plc, an Irish international sales, marketing and support services group. DCC Healthcare offers devices used in minimally invasive surgeries and related procedures in therapy areas such as gastroenterology and urology, as well as offers nutritional supplements and beauty products. DCC Healthcare serves customers worldwide.
Founded in 1990, Investindustrial is a private equity firm headquartered in London, United Kingdom. The firm seeks to invest in companies operating in the consumer and leisure, healthcare and services, industrial manufacturing and technology sectors based in the Southern European region.
The acquisition of DCC Healthcare allows Investindustrial to leverage its track record and expertise in the food supplement contract development and manufacturing organization and medical devices verticals. The deal is expected to complete in Q3 2025.
According to data captured in the LevinPro HC database, this marks the 39th Medical Device transaction of 2025. There were 87 Medical Device acquisitions announced during 2024, 112 announced in 2023 and 124 announced during 2022.
